Over 10,000 people in Spain have died after testing positive for coronavirus (Covid-19), as the global number of infections moves closer to a million. Around 50,000 people around the world have died so far during the pandemic. The real figures are believed to be much higher because of testing shortages, differences in counting the dead, and large numbers of mild cases that have gone unreported.
Spain reported a new record in virus-related deaths on Thursday, with 950 in 24 hours although the growth in infections is waning, health ministry data showed. Coronavirus infections rose by nearly 8% overnight to 110,238. The government has acknowledged that the real level of infection could be much higher because Spain only has the capacity of doing between 15,000 to 20,000 tests per day.
In Italy, with the most deaths of any country at around 14,000, mortuaries overflowed with bodies and coffins piled up in churches, although experts drew hope that the spread was already slowing in the country.
Over 4,000 people have died in France. And the UK has reported around 3,000 deaths.
In the US, New York is rushing to bring in an army of medical volunteers as the statewide death toll from coronavirus doubled in 72 hours to more than 1,900. As hot spots flared around the US in places like New Orleans and southern California, the nation’s biggest city was the hardest hit of all, with bodies loaded on to refrigerated mortuary trucks outside overwhelmed hospitals. Over 5,000 people had died in the US at the time of writing.
Donald Trump, meanwhile, acknowledged that the federal stockpile of personal protective equipment used by doctors and nurses is nearly depleted.
More than 6.6 million Americans applied for unemployment benefits last week. With a severe recession looming, this figure adds to the 3.3 million applications reported the previous week.
Scientists offered more evidence on Wednesday that the virus can be spread by seemingly healthy people who show no clear symptoms, leading the US government to issue new guidance warning that anyone exposed to the disease can be considered a potential carrier.
Many countries are modelling their response in part after China, which in January closed off an entire province, home to tens of millions of people, in what at the time was an unprecedented lockdown. Beijing says the measures have been a success, with nearly all new cases of the virus imported from abroad.
People in Wuhan, once the epicentre of the crisis, are starting to return to work. They are being tracked by a smartphone app that shows if they are symptom-free. The app is required to board a subway, check into a hotel or just enter the city.
Progress towards a potential vaccine?
Meanwhile, researchers say a fingertip-sized patch could be a potential vaccine for coronavirus. The vaccine is described in a paper published in EBioMedicine, which is published by The Lancet, and is thought to be the first to be reviewed by other scientists.
Researchers at the University of Pittsburgh School of Medicine say they were able to act quickly because they had laid the groundwork during earlier coronavirus epidemics. They have called their drug PittCoVacc, short for Pittsburgh Coronavirus Vaccine, and it uses lab-made pieces of viral protein to build immunity – the same way that current flu jabs work.
The researchers also used a novel approach to deliver the drug, called a microneedle array, to increase potency. This array is a fingertip-sized patch of 400 tiny needles that delivers ‘spike protein’ pieces into the skin, where the immune reaction is strongest. The patch is applied like a plaster and then the needles, which are made entirely of sugar and the protein pieces, simply dissolve into the skin.
Researchers say their system can be mass produced, and once manufactured, the vaccine can sit at room temperature until it is needed, eliminating the need for refrigeration during transport or storage.
The authors are now in the process of applying for an investigational new drug approval from the US Food and Drug Administration in anticipation of starting a phase I human clinical trial in the next few months.
We need your help to keep speaking the truth
Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.
Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.
We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.
In return, you get:
* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop
Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.
With your help we can continue:
* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do
We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?